Financials
- Market Capitalization 617.88 M
- Employee 371
- Founded 2008
- CEO N/A
- Website www.regenxbio.com
- Headquarter Maryland, United States
- FIGI BBG007Z9V591
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.16
ratio cours/chiffre d'affaires
3.61
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2756 | ALT Altimmune, Inc. - Common Stock | 3.26 USD | +5.50% | +4.82% | +13.19% | -12.83% | 634.13 M USD | ||
| 2771 | AUTL Autolus Therapeutics plc - American Depositary Shares | 2.28 USD | -1.30% | -2.56% | +32.56% | +57.24% | 606.85 M USD | ||
| 2775 | MPLT MapLight Therapeutics, Inc. - Common Stock | 13.05 USD | -1.95% | +7.05% | +1.56% | -31.32% | 605.23 M USD | ||
| 2777 | ARVN Arvinas, Inc. - Common Stock | 9.42 USD | +1.51% | +0.53% | +16.30% | +1.29% | 615.94 M USD |